Algae

Photosynthetic organisms that convert CO₂ into biomass and algal oil, which are then further processed into end products for the food, fuel, and chemicals industries.

LUX TAKE:

Algae innovation is now dominated by large corporations following the collapse of the startup space in the mid-2010s; companies initially focused on the fuel industry fast-tracked commercialization with subpar algae to capitalize on the hype, and most failed. The potential of algae now lies within the chemicals and nutrition sectors and is progressing fast. Despite the recent string of failures, ...

Data last updated on July 07, 2020

What's New

Lux Research analysts and the Lux Intelligence Engine have added the following recent algae developments.

News Commentaries

Neste launches feedstock R&D project to address likely supply shortage as the company continues to expand capacity (June 24, 2020)

Fermentalg secures $21.2 million in funding, forms alliance with DDW for blue colorant (June 24, 2020)

New Lux Content

An updated look into the processing and formulation toolbox for plant-based products (July 7, 2020)

Conagen (June 25, 2020)

New Patents

Computing...

New Investment Rounds

Computing...

Related companies	OriginClear, Algal Scientific Corporation, Fermentalg, Qualitas Health, AstaReal, T2Energy, SabrTech, Qponics, Euglena, Artveoli, Checkerspot

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978